2e82

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="2e82" size="450" color="white" frame="true" align="right" spinBox="true" caption="2e82, resolution 2.70&Aring;" /> '''Crystal structure o...)
Line 1: Line 1:
-
[[Image:2e82.gif|left|200px]]<br />
+
[[Image:2e82.gif|left|200px]]<br /><applet load="2e82" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="2e82" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="2e82, resolution 2.70&Aring;" />
caption="2e82, resolution 2.70&Aring;" />
'''Crystal structure of human D-amino acid oxidase complexed with imino-DOPA'''<br />
'''Crystal structure of human D-amino acid oxidase complexed with imino-DOPA'''<br />
==Overview==
==Overview==
-
d-Amino acid oxidase (DAO) degrades the gliotransmitter d-serine, a potent, endogenous ligand of N-methyl-d-aspartate type glutamate receptors. It, also has been suggested that d-DOPA, the stereoisomer of l-DOPA, is, oxidized by DAO and then converted to dopamine via an alternative, biosynthetic pathway. Here, we provide direct crystallographic evidence, that d-DOPA is readily fitted into the active site of human DAO, where it, is oxidized by the enzyme. Moreover, our kinetic data show that the, maximal velocity for oxidation of d-DOPA is much greater than for, d-serine, which strongly supports the proposed alternative pathway for, dopamine biosynthesis in the treatment of Parkinson's disease. In, addition, determination of the structures of human DAO in various states, revealed that the conformation of the hydrophobic VAAGL stretch (residues, 47-51) to be uniquely stable in the human enzyme, which provides a, structural basis for the unique kinetic features of human DAO.
+
D-amino acid oxidase (DAO) degrades the gliotransmitter D-serine, a potent endogenous ligand of N-methyl-D-aspartate type glutamate receptors. It also has been suggested that D-DOPA, the stereoisomer of L-DOPA, is oxidized by DAO and then converted to dopamine via an alternative biosynthetic pathway. Here, we provide direct crystallographic evidence that D-DOPA is readily fitted into the active site of human DAO, where it is oxidized by the enzyme. Moreover, our kinetic data show that the maximal velocity for oxidation of D-DOPA is much greater than for D-serine, which strongly supports the proposed alternative pathway for dopamine biosynthesis in the treatment of Parkinson's disease. In addition, determination of the structures of human DAO in various states revealed that the conformation of the hydrophobic VAAGL stretch (residues 47-51) to be uniquely stable in the human enzyme, which provides a structural basis for the unique kinetic features of human DAO.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
2E82 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with FAD and IM3 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/D-amino-acid_oxidase D-amino-acid oxidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.4.3.3 1.4.3.3] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2E82 OCA].
+
2E82 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=FAD:'>FAD</scene> and <scene name='pdbligand=IM3:'>IM3</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/D-amino-acid_oxidase D-amino-acid oxidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.4.3.3 1.4.3.3] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2E82 OCA].
==Reference==
==Reference==
-
Structural basis of d-DOPA oxidation by d-amino acid oxidase: Alternative pathway for dopamine biosynthesis., Kawazoe T, Tsuge H, Imagawa T, Aki K, Kuramitsu S, Fukui K, Biochem Biophys Res Commun. 2007 Apr 6;355(2):385-91. Epub 2007 Feb 8. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=17303072 17303072]
+
Structural basis of D-DOPA oxidation by D-amino acid oxidase: alternative pathway for dopamine biosynthesis., Kawazoe T, Tsuge H, Imagawa T, Aki K, Kuramitsu S, Fukui K, Biochem Biophys Res Commun. 2007 Apr 6;355(2):385-91. Epub 2007 Feb 8. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=17303072 17303072]
[[Category: D-amino-acid oxidase]]
[[Category: D-amino-acid oxidase]]
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
Line 28: Line 27:
[[Category: structurally ambivalent peptide]]
[[Category: structurally ambivalent peptide]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 21:46:55 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:07:08 2008''

Revision as of 15:07, 21 February 2008


2e82, resolution 2.70Å

Drag the structure with the mouse to rotate

Crystal structure of human D-amino acid oxidase complexed with imino-DOPA

Contents

Overview

D-amino acid oxidase (DAO) degrades the gliotransmitter D-serine, a potent endogenous ligand of N-methyl-D-aspartate type glutamate receptors. It also has been suggested that D-DOPA, the stereoisomer of L-DOPA, is oxidized by DAO and then converted to dopamine via an alternative biosynthetic pathway. Here, we provide direct crystallographic evidence that D-DOPA is readily fitted into the active site of human DAO, where it is oxidized by the enzyme. Moreover, our kinetic data show that the maximal velocity for oxidation of D-DOPA is much greater than for D-serine, which strongly supports the proposed alternative pathway for dopamine biosynthesis in the treatment of Parkinson's disease. In addition, determination of the structures of human DAO in various states revealed that the conformation of the hydrophobic VAAGL stretch (residues 47-51) to be uniquely stable in the human enzyme, which provides a structural basis for the unique kinetic features of human DAO.

Disease

Known diseases associated with this structure: Schizophrenia OMIM:[124050]

About this Structure

2E82 is a Single protein structure of sequence from Homo sapiens with and as ligands. Active as D-amino-acid oxidase, with EC number 1.4.3.3 Full crystallographic information is available from OCA.

Reference

Structural basis of D-DOPA oxidation by D-amino acid oxidase: alternative pathway for dopamine biosynthesis., Kawazoe T, Tsuge H, Imagawa T, Aki K, Kuramitsu S, Fukui K, Biochem Biophys Res Commun. 2007 Apr 6;355(2):385-91. Epub 2007 Feb 8. PMID:17303072

Page seeded by OCA on Thu Feb 21 17:07:08 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools